MTOR and prostate carcinoma: Recent studies indicate that the complex crosstalk between the phosphatidylinositol-3-kinase-protein kinaseB-mammalian target of rapamycin pathway and multiple interacting cell signaling cascades can further promote prostate cancer progression15.